Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of PreveCol's Efficiency As a Second Line Method for the Early Colorectal Cancer Detection

NCT06703632 is registered in ClinicalTrials.gov with ADVANCED MARKER DISCOVERY S.L. as lead sponsor.

NCT NCT06703632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06703632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of PreveCol's Efficiency As a Second Line Method for the Early Colorectal Cancer Detection
Lead sponsor
ADVANCED MARKER DISCOVERY S.L.
Phase
Not applicable
Overall status
Recruiting
Start date
January 14, 2025
Completion date
December 31, 2025
Enrollment
4,538 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

blood samples, colon adenocarcinoma, colorectal carcinoma, precancerous lesion of colon, screening for colon cancer, survey and questionnaire